Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis

Pharmacopsychiatry

Volumn 37, Issue 3, 2004, Pages 93-97

  Barbui, C ^a,d   Guaiana, G ^b   Hotopf, M ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA ANALYSIS; DISEASE SEVERITY; DRUG TOLERABILITY; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; LINEAR REGRESSION ANALYSIS; MAJOR DEPRESSION; MEDICAL RECORD; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ADRENERGIC UPTAKE INHIBITORS; AMITRIPTYLINE; DEPRESSION; DRUG EVALUATION; HUMANS; INPATIENTS; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SEROTONIN UPTAKE INHIBITORS;

EID: 2542497043     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818985     Document Type: Review

References (15)

1. Altman DG, Bland JM. Detecting skewness from summary information. Br Med J 1996; 313: 1200
2. American Psychiatric Association. Practice Guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157 (suppl): 1-45
3. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J Affect Disord 2000; 58: 19-36
4. Anderson IM. SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability. Depress Anxiety 1998; suppl 1: 11-17
5. Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001; 57: 161-178
6. Barbui C, Hotopf M. Amitriptyline versus the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br J Psychiatry 2001; 178: 129-144
7. Bruijn JA, Moleman P, Mulder PG, van den Broek WW. Depressed inpatients respond differently to imipramine and mirtazapine. Pharmacopsychiatry 1999; 32: 87-92
8. Freemantle N, Anderson IM, Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. Br J Psychiatry 2000; 177: 292-302
9. Joffe R, Sokolov S, Streiner D. Antidepressant treatment of depression. A meta-analysis. Can J Psychiatry 1996; 41: 613-616
10. Kennedy SH, Lam RW, Cohen NL, et al. Clinical Guidelines for the treatment of depressive disorders IV. Medications and other biological treatments. Can J Psychiatry 2001; 46 (suppl 1): S38-58
11. Laux G. Cost-benefit analysis of newer versus older antidepressants - pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants. Pharmacopsychiatry 2001; 34: 1-5
12. Moncrieff J, Churchill R, Drummond DC,et al. Development of a quality assessment instrument for trials of treatments for depression and neurosis. Int J Methods Psychiatr Res 2001; 10: 126-133
13. Perry PJ. Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 1996; 39: 1-6
14. Spigset O, Martensson B. Drug treatment of depression. Br Med J 1999; 318: 1188-1191
15. Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1995; 14: 2057-2079